A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.
Identifieur interne : 002781 ( PubMed/Curation ); précédent : 002780; suivant : 002782A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.
Auteurs : Ben J. Gu [Australie] ; Judith Field [Australie] ; Sébastien Dutertre [France] ; Amber Ou [Australie] ; Trevor J. Kilpatrick [Australie] ; Jeannette Lechner-Scott [Australie] ; Rodney Scott [Australie] ; Rodney Lea [Australie] ; Bruce V. Taylor [Australie] ; Jim Stankovich [Australie] ; Helmut Butzkueven [Australie] ; Melissa Gresle [Australie] ; Simon M. Laws [Australie] ; Steven Petrou [Australie] ; Sabine Hoffjan [Allemagne] ; Denis A. Akkad [Allemagne] ; Colin A. Graham [Royaume-Uni] ; Stanley Hawkins [Royaume-Uni] ; Anna Glaser [Suède] ; Sahl Khalid Bedri [Suède] ; Jan Hillert [Suède] ; Carlos Matute ; Alfredo Antiguedad [Espagne] ; James S. Wiley [Australie]Source :
- Human molecular genetics [ 1460-2083 ] ; 2015.
Descripteurs français
- KwdFr :
- Adénosine triphosphate (métabolisme), Arginine (métabolisme), Australasie, Glutamine (métabolisme), Humains, Modèles moléculaires, Population d'origine européenne (génétique), Prédisposition génétique à une maladie, Récepteurs purinergiques P2X7 (), Récepteurs purinergiques P2X7 (génétique), Récepteurs purinergiques P2X7 (métabolisme), Sclérose en plaques (anatomopathologie), Sclérose en plaques (génétique), Sclérose en plaques (métabolisme), Sites de fixation, Substitution d'acide aminé, Études d'associations génétiques.
- MESH :
- anatomopathologie : Sclérose en plaques.
- génétique : Population d'origine européenne, Récepteurs purinergiques P2X7, Sclérose en plaques.
- métabolisme : Adénosine triphosphate, Arginine, Glutamine, Récepteurs purinergiques P2X7, Sclérose en plaques.
- Australasie, Humains, Modèles moléculaires, Prédisposition génétique à une maladie, Récepteurs purinergiques P2X7, Sites de fixation, Substitution d'acide aminé, Études d'associations génétiques.
English descriptors
- KwdEn :
- Adenosine Triphosphate (metabolism), Amino Acid Substitution, Arginine (metabolism), Australasia, Binding Sites, European Continental Ancestry Group (genetics), Genetic Association Studies, Genetic Predisposition to Disease, Glutamine (metabolism), Humans, Models, Molecular, Multiple Sclerosis (genetics), Multiple Sclerosis (metabolism), Multiple Sclerosis (pathology), Receptors, Purinergic P2X7 (chemistry), Receptors, Purinergic P2X7 (genetics), Receptors, Purinergic P2X7 (metabolism).
- MESH :
- chemical , chemistry : Receptors, Purinergic P2X7.
- chemical , genetics : Receptors, Purinergic P2X7.
- chemical , metabolism : Adenosine Triphosphate, Arginine, Glutamine, Receptors, Purinergic P2X7.
- geographic : Australasia.
- genetics : European Continental Ancestry Group, Multiple Sclerosis.
- metabolism : Multiple Sclerosis.
- pathology : Multiple Sclerosis.
- Amino Acid Substitution, Binding Sites, Genetic Association Studies, Genetic Predisposition to Disease, Humans, Models, Molecular.
Abstract
Multiple sclerosis (MS) is a chronic relapsing-remitting inflammatory disease of the central nervous system characterized by oligodendrocyte damage, demyelination and neuronal death. Genetic association studies have shown a 2-fold or greater prevalence of the HLA-DRB1*1501 allele in the MS population compared with normal Caucasians. In discovery cohorts of Australasian patients with MS (total 2941 patients and 3008 controls), we examined the associations of 12 functional polymorphisms of P2X7, a microglial/macrophage receptor with proinflammatory effects when activated by extracellular adenosine triphosphate (ATP). In discovery cohorts, rs28360457, coding for Arg307Gln was associated with MS and combined analysis showed a 2-fold lower minor allele frequency compared with controls (1.11% for MS and 2.15% for controls, P = 0.0000071). Replication analysis of four independent European MS case-control cohorts (total 2140 cases and 2634 controls) confirmed this association [odds ratio (OR) = 0.69, P = 0.026]. A meta-analysis of all Australasian and European cohorts indicated that Arg307Gln confers a 1.8-fold protective effect on MS risk (OR = 0.57, P = 0.0000024). Fresh human monocytes heterozygous for Arg307Gln have >85% loss of 'pore' function of the P2X7 receptor measured by ATP-induced ethidium uptake. Analysis shows Arg307Gln always occurred with 270His suggesting a single 307Gln-270His haplotype that confers dominant negative effects on P2X7 function and protection against MS. Modeling based on the homologous zP2X4 receptor showed Arg307 is located in a region rich in basic residues located only 12 Å from the ligand binding site. Our data show the protective effect against MS of a rare genetic variant of P2RX7 with heterozygotes showing near absent proinflammatory 'pore' function.
DOI: 10.1093/hmg/ddv278
PubMed: 26188005
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002850
Links to Exploration step
pubmed:26188005Curation
No country items
Carlos Matute<affiliation><nlm:affiliation>CIBERNED, Achucarro Basque Center for Neuroscience, and Departamento de Neurociencias, Universidad del País Vasco, Leioa, Spain and.</nlm:affiliation>
<wicri:noCountry code="subField">Spain and</wicri:noCountry>
</affiliation>
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.</title>
<author><name sortKey="Gu, Ben J" sort="Gu, Ben J" uniqKey="Gu B" first="Ben J" last="Gu">Ben J. Gu</name>
<affiliation wicri:level="1"><nlm:affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Field, Judith" sort="Field, Judith" uniqKey="Field J" first="Judith" last="Field">Judith Field</name>
<affiliation wicri:level="1"><nlm:affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Dutertre, Sebastien" sort="Dutertre, Sebastien" uniqKey="Dutertre S" first="Sébastien" last="Dutertre">Sébastien Dutertre</name>
<affiliation wicri:level="1"><nlm:affiliation>Institut des Biomolécules Max Mousseron, UMR 5247, Université Montpellier 2-CNRS, Montpellier, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut des Biomolécules Max Mousseron, UMR 5247, Université Montpellier 2-CNRS, Montpellier</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ou, Amber" sort="Ou, Amber" uniqKey="Ou A" first="Amber" last="Ou">Amber Ou</name>
<affiliation wicri:level="1"><nlm:affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kilpatrick, Trevor J" sort="Kilpatrick, Trevor J" uniqKey="Kilpatrick T" first="Trevor J" last="Kilpatrick">Trevor J. Kilpatrick</name>
<affiliation wicri:level="1"><nlm:affiliation>Melbourne Neuroscience Institute, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Melbourne Neuroscience Institute, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lechner Scott, Jeannette" sort="Lechner Scott, Jeannette" uniqKey="Lechner Scott J" first="Jeannette" last="Lechner-Scott">Jeannette Lechner-Scott</name>
<affiliation wicri:level="1"><nlm:affiliation>Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Scott, Rodney" sort="Scott, Rodney" uniqKey="Scott R" first="Rodney" last="Scott">Rodney Scott</name>
<affiliation wicri:level="1"><nlm:affiliation>Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lea, Rodney" sort="Lea, Rodney" uniqKey="Lea R" first="Rodney" last="Lea">Rodney Lea</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Taylor, Bruce V" sort="Taylor, Bruce V" uniqKey="Taylor B" first="Bruce V" last="Taylor">Bruce V. Taylor</name>
<affiliation wicri:level="1"><nlm:affiliation>Menzies Institute, University of Tasmania, Hobart, Tasmania, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Menzies Institute, University of Tasmania, Hobart, Tasmania</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Stankovich, Jim" sort="Stankovich, Jim" uniqKey="Stankovich J" first="Jim" last="Stankovich">Jim Stankovich</name>
<affiliation wicri:level="1"><nlm:affiliation>Menzies Institute, University of Tasmania, Hobart, Tasmania, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Menzies Institute, University of Tasmania, Hobart, Tasmania</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Butzkueven, Helmut" sort="Butzkueven, Helmut" uniqKey="Butzkueven H" first="Helmut" last="Butzkueven">Helmut Butzkueven</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Gresle, Melissa" sort="Gresle, Melissa" uniqKey="Gresle M" first="Melissa" last="Gresle">Melissa Gresle</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Laws, Simon M" sort="Laws, Simon M" uniqKey="Laws S" first="Simon M" last="Laws">Simon M. Laws</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Medical Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Medical Sciences, Edith Cowan University, Joondalup, Western Australia</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Petrou, Steven" sort="Petrou, Steven" uniqKey="Petrou S" first="Steven" last="Petrou">Steven Petrou</name>
<affiliation wicri:level="1"><nlm:affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hoffjan, Sabine" sort="Hoffjan, Sabine" uniqKey="Hoffjan S" first="Sabine" last="Hoffjan">Sabine Hoffjan</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Human Genetics, Ruhr-University Bochum, Bochum, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Human Genetics, Ruhr-University Bochum, Bochum</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Akkad, Denis A" sort="Akkad, Denis A" uniqKey="Akkad D" first="Denis A" last="Akkad">Denis A. Akkad</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Human Genetics, Ruhr-University Bochum, Bochum, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Human Genetics, Ruhr-University Bochum, Bochum</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Graham, Colin A" sort="Graham, Colin A" uniqKey="Graham C" first="Colin A" last="Graham">Colin A. Graham</name>
<affiliation wicri:level="1"><nlm:affiliation>Regional Genetics Laboratories, Belfast Health & Social Care Trust, Northern Ireland, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Regional Genetics Laboratories, Belfast Health & Social Care Trust, Northern Ireland</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hawkins, Stanley" sort="Hawkins, Stanley" uniqKey="Hawkins S" first="Stanley" last="Hawkins">Stanley Hawkins</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, Belfast Health & Social Care Trust, Northern Ireland, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, Belfast Health & Social Care Trust, Northern Ireland</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Glaser, Anna" sort="Glaser, Anna" uniqKey="Glaser A" first="Anna" last="Glaser">Anna Glaser</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Clinical Neurosciences, Karolinska Institutet, Stockholm</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bedri, Sahl Khalid" sort="Bedri, Sahl Khalid" uniqKey="Bedri S" first="Sahl Khalid" last="Bedri">Sahl Khalid Bedri</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Clinical Neurosciences, Karolinska Institutet, Stockholm</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hillert, Jan" sort="Hillert, Jan" uniqKey="Hillert J" first="Jan" last="Hillert">Jan Hillert</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Clinical Neurosciences, Karolinska Institutet, Stockholm</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Matute, Carlos" sort="Matute, Carlos" uniqKey="Matute C" first="Carlos" last="Matute">Carlos Matute</name>
<affiliation><nlm:affiliation>CIBERNED, Achucarro Basque Center for Neuroscience, and Departamento de Neurociencias, Universidad del País Vasco, Leioa, Spain and.</nlm:affiliation>
<wicri:noCountry code="subField">Spain and</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Antiguedad, Alfredo" sort="Antiguedad, Alfredo" uniqKey="Antiguedad A" first="Alfredo" last="Antiguedad">Alfredo Antiguedad</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio de Neurología, Hospital Universitario Basurto-Osakidetza, Bilbao, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Neurología, Hospital Universitario Basurto-Osakidetza, Bilbao</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wiley, James S" sort="Wiley, James S" uniqKey="Wiley J" first="James S" last="Wiley">James S. Wiley</name>
<affiliation wicri:level="1"><nlm:affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia, james.wiley@florey.edu.au.</nlm:affiliation>
<country wicri:rule="url">Australie</country>
<wicri:regionArea>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26188005</idno>
<idno type="pmid">26188005</idno>
<idno type="doi">10.1093/hmg/ddv278</idno>
<idno type="wicri:Area/PubMed/Corpus">002850</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002850</idno>
<idno type="wicri:Area/PubMed/Curation">002781</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002781</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.</title>
<author><name sortKey="Gu, Ben J" sort="Gu, Ben J" uniqKey="Gu B" first="Ben J" last="Gu">Ben J. Gu</name>
<affiliation wicri:level="1"><nlm:affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Field, Judith" sort="Field, Judith" uniqKey="Field J" first="Judith" last="Field">Judith Field</name>
<affiliation wicri:level="1"><nlm:affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Dutertre, Sebastien" sort="Dutertre, Sebastien" uniqKey="Dutertre S" first="Sébastien" last="Dutertre">Sébastien Dutertre</name>
<affiliation wicri:level="1"><nlm:affiliation>Institut des Biomolécules Max Mousseron, UMR 5247, Université Montpellier 2-CNRS, Montpellier, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut des Biomolécules Max Mousseron, UMR 5247, Université Montpellier 2-CNRS, Montpellier</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ou, Amber" sort="Ou, Amber" uniqKey="Ou A" first="Amber" last="Ou">Amber Ou</name>
<affiliation wicri:level="1"><nlm:affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kilpatrick, Trevor J" sort="Kilpatrick, Trevor J" uniqKey="Kilpatrick T" first="Trevor J" last="Kilpatrick">Trevor J. Kilpatrick</name>
<affiliation wicri:level="1"><nlm:affiliation>Melbourne Neuroscience Institute, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Melbourne Neuroscience Institute, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lechner Scott, Jeannette" sort="Lechner Scott, Jeannette" uniqKey="Lechner Scott J" first="Jeannette" last="Lechner-Scott">Jeannette Lechner-Scott</name>
<affiliation wicri:level="1"><nlm:affiliation>Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Scott, Rodney" sort="Scott, Rodney" uniqKey="Scott R" first="Rodney" last="Scott">Rodney Scott</name>
<affiliation wicri:level="1"><nlm:affiliation>Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lea, Rodney" sort="Lea, Rodney" uniqKey="Lea R" first="Rodney" last="Lea">Rodney Lea</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Taylor, Bruce V" sort="Taylor, Bruce V" uniqKey="Taylor B" first="Bruce V" last="Taylor">Bruce V. Taylor</name>
<affiliation wicri:level="1"><nlm:affiliation>Menzies Institute, University of Tasmania, Hobart, Tasmania, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Menzies Institute, University of Tasmania, Hobart, Tasmania</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Stankovich, Jim" sort="Stankovich, Jim" uniqKey="Stankovich J" first="Jim" last="Stankovich">Jim Stankovich</name>
<affiliation wicri:level="1"><nlm:affiliation>Menzies Institute, University of Tasmania, Hobart, Tasmania, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Menzies Institute, University of Tasmania, Hobart, Tasmania</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Butzkueven, Helmut" sort="Butzkueven, Helmut" uniqKey="Butzkueven H" first="Helmut" last="Butzkueven">Helmut Butzkueven</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Gresle, Melissa" sort="Gresle, Melissa" uniqKey="Gresle M" first="Melissa" last="Gresle">Melissa Gresle</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Laws, Simon M" sort="Laws, Simon M" uniqKey="Laws S" first="Simon M" last="Laws">Simon M. Laws</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Medical Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Medical Sciences, Edith Cowan University, Joondalup, Western Australia</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Petrou, Steven" sort="Petrou, Steven" uniqKey="Petrou S" first="Steven" last="Petrou">Steven Petrou</name>
<affiliation wicri:level="1"><nlm:affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hoffjan, Sabine" sort="Hoffjan, Sabine" uniqKey="Hoffjan S" first="Sabine" last="Hoffjan">Sabine Hoffjan</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Human Genetics, Ruhr-University Bochum, Bochum, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Human Genetics, Ruhr-University Bochum, Bochum</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Akkad, Denis A" sort="Akkad, Denis A" uniqKey="Akkad D" first="Denis A" last="Akkad">Denis A. Akkad</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Human Genetics, Ruhr-University Bochum, Bochum, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Human Genetics, Ruhr-University Bochum, Bochum</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Graham, Colin A" sort="Graham, Colin A" uniqKey="Graham C" first="Colin A" last="Graham">Colin A. Graham</name>
<affiliation wicri:level="1"><nlm:affiliation>Regional Genetics Laboratories, Belfast Health & Social Care Trust, Northern Ireland, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Regional Genetics Laboratories, Belfast Health & Social Care Trust, Northern Ireland</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hawkins, Stanley" sort="Hawkins, Stanley" uniqKey="Hawkins S" first="Stanley" last="Hawkins">Stanley Hawkins</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, Belfast Health & Social Care Trust, Northern Ireland, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, Belfast Health & Social Care Trust, Northern Ireland</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Glaser, Anna" sort="Glaser, Anna" uniqKey="Glaser A" first="Anna" last="Glaser">Anna Glaser</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Clinical Neurosciences, Karolinska Institutet, Stockholm</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bedri, Sahl Khalid" sort="Bedri, Sahl Khalid" uniqKey="Bedri S" first="Sahl Khalid" last="Bedri">Sahl Khalid Bedri</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Clinical Neurosciences, Karolinska Institutet, Stockholm</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hillert, Jan" sort="Hillert, Jan" uniqKey="Hillert J" first="Jan" last="Hillert">Jan Hillert</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Clinical Neurosciences, Karolinska Institutet, Stockholm</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Matute, Carlos" sort="Matute, Carlos" uniqKey="Matute C" first="Carlos" last="Matute">Carlos Matute</name>
<affiliation><nlm:affiliation>CIBERNED, Achucarro Basque Center for Neuroscience, and Departamento de Neurociencias, Universidad del País Vasco, Leioa, Spain and.</nlm:affiliation>
<wicri:noCountry code="subField">Spain and</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Antiguedad, Alfredo" sort="Antiguedad, Alfredo" uniqKey="Antiguedad A" first="Alfredo" last="Antiguedad">Alfredo Antiguedad</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio de Neurología, Hospital Universitario Basurto-Osakidetza, Bilbao, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Neurología, Hospital Universitario Basurto-Osakidetza, Bilbao</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wiley, James S" sort="Wiley, James S" uniqKey="Wiley J" first="James S" last="Wiley">James S. Wiley</name>
<affiliation wicri:level="1"><nlm:affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia, james.wiley@florey.edu.au.</nlm:affiliation>
<country wicri:rule="url">Australie</country>
<wicri:regionArea>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Human molecular genetics</title>
<idno type="eISSN">1460-2083</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenosine Triphosphate (metabolism)</term>
<term>Amino Acid Substitution</term>
<term>Arginine (metabolism)</term>
<term>Australasia</term>
<term>Binding Sites</term>
<term>European Continental Ancestry Group (genetics)</term>
<term>Genetic Association Studies</term>
<term>Genetic Predisposition to Disease</term>
<term>Glutamine (metabolism)</term>
<term>Humans</term>
<term>Models, Molecular</term>
<term>Multiple Sclerosis (genetics)</term>
<term>Multiple Sclerosis (metabolism)</term>
<term>Multiple Sclerosis (pathology)</term>
<term>Receptors, Purinergic P2X7 (chemistry)</term>
<term>Receptors, Purinergic P2X7 (genetics)</term>
<term>Receptors, Purinergic P2X7 (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adénosine triphosphate (métabolisme)</term>
<term>Arginine (métabolisme)</term>
<term>Australasie</term>
<term>Glutamine (métabolisme)</term>
<term>Humains</term>
<term>Modèles moléculaires</term>
<term>Population d'origine européenne (génétique)</term>
<term>Prédisposition génétique à une maladie</term>
<term>Récepteurs purinergiques P2X7 ()</term>
<term>Récepteurs purinergiques P2X7 (génétique)</term>
<term>Récepteurs purinergiques P2X7 (métabolisme)</term>
<term>Sclérose en plaques (anatomopathologie)</term>
<term>Sclérose en plaques (génétique)</term>
<term>Sclérose en plaques (métabolisme)</term>
<term>Sites de fixation</term>
<term>Substitution d'acide aminé</term>
<term>Études d'associations génétiques</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Receptors, Purinergic P2X7</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Receptors, Purinergic P2X7</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Adenosine Triphosphate</term>
<term>Arginine</term>
<term>Glutamine</term>
<term>Receptors, Purinergic P2X7</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Australasia</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Sclérose en plaques</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>European Continental Ancestry Group</term>
<term>Multiple Sclerosis</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Population d'origine européenne</term>
<term>Récepteurs purinergiques P2X7</term>
<term>Sclérose en plaques</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Multiple Sclerosis</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Adénosine triphosphate</term>
<term>Arginine</term>
<term>Glutamine</term>
<term>Récepteurs purinergiques P2X7</term>
<term>Sclérose en plaques</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Multiple Sclerosis</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Amino Acid Substitution</term>
<term>Binding Sites</term>
<term>Genetic Association Studies</term>
<term>Genetic Predisposition to Disease</term>
<term>Humans</term>
<term>Models, Molecular</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Australasie</term>
<term>Humains</term>
<term>Modèles moléculaires</term>
<term>Prédisposition génétique à une maladie</term>
<term>Récepteurs purinergiques P2X7</term>
<term>Sites de fixation</term>
<term>Substitution d'acide aminé</term>
<term>Études d'associations génétiques</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Multiple sclerosis (MS) is a chronic relapsing-remitting inflammatory disease of the central nervous system characterized by oligodendrocyte damage, demyelination and neuronal death. Genetic association studies have shown a 2-fold or greater prevalence of the HLA-DRB1*1501 allele in the MS population compared with normal Caucasians. In discovery cohorts of Australasian patients with MS (total 2941 patients and 3008 controls), we examined the associations of 12 functional polymorphisms of P2X7, a microglial/macrophage receptor with proinflammatory effects when activated by extracellular adenosine triphosphate (ATP). In discovery cohorts, rs28360457, coding for Arg307Gln was associated with MS and combined analysis showed a 2-fold lower minor allele frequency compared with controls (1.11% for MS and 2.15% for controls, P = 0.0000071). Replication analysis of four independent European MS case-control cohorts (total 2140 cases and 2634 controls) confirmed this association [odds ratio (OR) = 0.69, P = 0.026]. A meta-analysis of all Australasian and European cohorts indicated that Arg307Gln confers a 1.8-fold protective effect on MS risk (OR = 0.57, P = 0.0000024). Fresh human monocytes heterozygous for Arg307Gln have >85% loss of 'pore' function of the P2X7 receptor measured by ATP-induced ethidium uptake. Analysis shows Arg307Gln always occurred with 270His suggesting a single 307Gln-270His haplotype that confers dominant negative effects on P2X7 function and protection against MS. Modeling based on the homologous zP2X4 receptor showed Arg307 is located in a region rich in basic residues located only 12 Å from the ligand binding site. Our data show the protective effect against MS of a rare genetic variant of P2RX7 with heterozygotes showing near absent proinflammatory 'pore' function.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26188005</PMID>
<DateCreated><Year>2015</Year>
<Month>09</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted><Year>2016</Year>
<Month>07</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>09</Month>
<Day>16</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2083</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>24</Volume>
<Issue>19</Issue>
<PubDate><Year>2015</Year>
<Month>Oct</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>Human molecular genetics</Title>
<ISOAbbreviation>Hum. Mol. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.</ArticleTitle>
<Pagination><MedlinePgn>5644-54</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/hmg/ddv278</ELocationID>
<Abstract><AbstractText>Multiple sclerosis (MS) is a chronic relapsing-remitting inflammatory disease of the central nervous system characterized by oligodendrocyte damage, demyelination and neuronal death. Genetic association studies have shown a 2-fold or greater prevalence of the HLA-DRB1*1501 allele in the MS population compared with normal Caucasians. In discovery cohorts of Australasian patients with MS (total 2941 patients and 3008 controls), we examined the associations of 12 functional polymorphisms of P2X7, a microglial/macrophage receptor with proinflammatory effects when activated by extracellular adenosine triphosphate (ATP). In discovery cohorts, rs28360457, coding for Arg307Gln was associated with MS and combined analysis showed a 2-fold lower minor allele frequency compared with controls (1.11% for MS and 2.15% for controls, P = 0.0000071). Replication analysis of four independent European MS case-control cohorts (total 2140 cases and 2634 controls) confirmed this association [odds ratio (OR) = 0.69, P = 0.026]. A meta-analysis of all Australasian and European cohorts indicated that Arg307Gln confers a 1.8-fold protective effect on MS risk (OR = 0.57, P = 0.0000024). Fresh human monocytes heterozygous for Arg307Gln have >85% loss of 'pore' function of the P2X7 receptor measured by ATP-induced ethidium uptake. Analysis shows Arg307Gln always occurred with 270His suggesting a single 307Gln-270His haplotype that confers dominant negative effects on P2X7 function and protection against MS. Modeling based on the homologous zP2X4 receptor showed Arg307 is located in a region rich in basic residues located only 12 Å from the ligand binding site. Our data show the protective effect against MS of a rare genetic variant of P2RX7 with heterozygotes showing near absent proinflammatory 'pore' function.</AbstractText>
<CopyrightInformation>© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gu</LastName>
<ForeName>Ben J</ForeName>
<Initials>BJ</Initials>
<AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Field</LastName>
<ForeName>Judith</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dutertre</LastName>
<ForeName>Sébastien</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Institut des Biomolécules Max Mousseron, UMR 5247, Université Montpellier 2-CNRS, Montpellier, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ou</LastName>
<ForeName>Amber</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kilpatrick</LastName>
<ForeName>Trevor J</ForeName>
<Initials>TJ</Initials>
<AffiliationInfo><Affiliation>Melbourne Neuroscience Institute, University of Melbourne, Parkville, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lechner-Scott</LastName>
<ForeName>Jeannette</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Scott</LastName>
<ForeName>Rodney</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lea</LastName>
<ForeName>Rodney</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Taylor</LastName>
<ForeName>Bruce V</ForeName>
<Initials>BV</Initials>
<AffiliationInfo><Affiliation>Menzies Institute, University of Tasmania, Hobart, Tasmania, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Stankovich</LastName>
<ForeName>Jim</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Menzies Institute, University of Tasmania, Hobart, Tasmania, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Butzkueven</LastName>
<ForeName>Helmut</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gresle</LastName>
<ForeName>Melissa</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Laws</LastName>
<ForeName>Simon M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo><Affiliation>School of Medical Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Petrou</LastName>
<ForeName>Steven</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hoffjan</LastName>
<ForeName>Sabine</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Human Genetics, Ruhr-University Bochum, Bochum, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Akkad</LastName>
<ForeName>Denis A</ForeName>
<Initials>DA</Initials>
<AffiliationInfo><Affiliation>Department of Human Genetics, Ruhr-University Bochum, Bochum, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Graham</LastName>
<ForeName>Colin A</ForeName>
<Initials>CA</Initials>
<AffiliationInfo><Affiliation>Regional Genetics Laboratories, Belfast Health & Social Care Trust, Northern Ireland, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hawkins</LastName>
<ForeName>Stanley</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Neurology, Belfast Health & Social Care Trust, Northern Ireland, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Glaser</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bedri</LastName>
<ForeName>Sahl Khalid</ForeName>
<Initials>SK</Initials>
<AffiliationInfo><Affiliation>Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hillert</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Matute</LastName>
<ForeName>Carlos</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>CIBERNED, Achucarro Basque Center for Neuroscience, and Departamento de Neurociencias, Universidad del País Vasco, Leioa, Spain and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Antiguedad</LastName>
<ForeName>Alfredo</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Servicio de Neurología, Hospital Universitario Basurto-Osakidetza, Bilbao, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>ANZgene Consortium</CollectiveName>
</Author>
<Author ValidYN="Y"><LastName>Wiley</LastName>
<ForeName>James S</ForeName>
<Initials>JS</Initials>
<AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia, james.wiley@florey.edu.au.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2015</Year>
<Month>07</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Hum Mol Genet</MedlineTA>
<NlmUniqueID>9208958</NlmUniqueID>
<ISSNLinking>0964-6906</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000602286">P2XR receptor, human</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D058486">Receptors, Purinergic P2X7</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0RH81L854J</RegistryNumber>
<NameOfSubstance UI="D005973">Glutamine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>8L70Q75FXE</RegistryNumber>
<NameOfSubstance UI="D000255">Adenosine Triphosphate</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>94ZLA3W45F</RegistryNumber>
<NameOfSubstance UI="D001120">Arginine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000255" MajorTopicYN="N">Adenosine Triphosphate</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019943" MajorTopicYN="Y">Amino Acid Substitution</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001120" MajorTopicYN="N">Arginine</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D044362" MajorTopicYN="N" Type="Geographic">Australasia</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D044465" MajorTopicYN="N">European Continental Ancestry Group</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005973" MajorTopicYN="N">Glutamine</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058486" MajorTopicYN="N">Receptors, Purinergic P2X7</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<InvestigatorList><Investigator ValidYN="Y"><LastName>Baxter</LastName>
<ForeName>Alan G</ForeName>
<Initials>AG</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kermode</LastName>
<ForeName>Allan G</ForeName>
<Initials>AG</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Taylor</LastName>
<ForeName>Bruce V</ForeName>
<Initials>BV</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Booth</LastName>
<ForeName>David R</ForeName>
<Initials>DR</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mason</LastName>
<ForeName>Deborah F</ForeName>
<Initials>DF</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Stewart</LastName>
<ForeName>Graeme J</ForeName>
<Initials>GJ</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Butzkueven</LastName>
<ForeName>Helmut</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Charlesworth</LastName>
<ForeName>Jac C</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Wiley</LastName>
<ForeName>James S</ForeName>
<Initials>JS</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lechner-Scott</LastName>
<ForeName>Jeannette S</ForeName>
<Initials>JS</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Field</LastName>
<ForeName>Judith</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Tajouri</LastName>
<ForeName>Lotti</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Griffiths</LastName>
<ForeName>Lyn R</ForeName>
<Initials>LR</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Slee</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Brown</LastName>
<ForeName>Matthew A</ForeName>
<Initials>MA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Moscato</LastName>
<ForeName>Pablo</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Scott</LastName>
<ForeName>Rodney J</ForeName>
<Initials>RJ</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Broadley</LastName>
<ForeName>Simon A</ForeName>
<Initials>SA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Vucic</LastName>
<ForeName>Steve</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kilpatrick</LastName>
<ForeName>Trevor J</ForeName>
<Initials>TJ</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Carroll</LastName>
<ForeName>William M</ForeName>
<Initials>WM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Barnett</LastName>
<ForeName>Michael H</ForeName>
<Initials>MH</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year>
<Month>05</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2015</Year>
<Month>07</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>7</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>7</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>7</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">26188005</ArticleId>
<ArticleId IdType="pii">ddv278</ArticleId>
<ArticleId IdType="doi">10.1093/hmg/ddv278</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002781 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002781 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:26188005 |texte= A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:26188005" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |